While there was a clear positive trend between higher hs-cTnT levels and increased incidence rates of cancer subtypes within the 3 highest categories, this trend was not consistently observed across all hs-cTnT categories, especially in the lower hs-cTnT categories, possibly due to relatively low incidence rate in these lower levels. The gene discussed is TNNT2; the disease is cancer.